Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study

Bibliographic Details
Title: Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
Authors: Girolamo Ranieri, Carmelo Laface, Mariarita Laforgia, Simona De Summa, Mariangela Porcelli, Francesco Macina, Michele Ammendola, Pasquale Molinari, Gianfranco Lauletta, Alessandra Di Palo, Giuseppe Rubini, Cristina Ferrari, Cosmo Damiano Gadaleta
Source: Frontiers in Oncology, Vol 10 (2021)
Publisher Information: Frontiers Media S.A., 2021.
Publication Year: 2021
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: tumor angiogenesis, bevacizumab, hyperthermia, chemotherapy, metastatic colon cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
44361947
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2020.637880/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2020.637880
Access URL: https://doaj.org/article/ea7a808c11b44361947ccbced352073c
Accession Number: edsdoj.7a808c11b44361947ccbced352073c
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
44361947
DOI:10.3389/fonc.2020.637880
Published in:Frontiers in Oncology
Language:English